MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jsat.2021.108593

Медицинская библиотека · Journal of substance abuse treatment · 2021

Qualitative characterizations of misinformed disclosure reactions to medications for opioid use disorders and their consequences.

Brousseau Natalie M, Farmer Heather, Karpyn Allison, Laurenceau Jean-Philippe, Kelly John F, Hill Elizabeth C, Earnshaw Valerie A

СтатьяПоддержка NIH: внешняя программаПоддержка службы здравоохранения СШАПеревод в очереди

Аннотация

INTRODUCTION

Methadone and buprenorphine/naloxone medications are among the most effective treatment options for opioid use disorders, yet many people remain misinformed about their benefits and hold negative perceptions about the use of medications to treat opioid use disorders. Such perceptions, especially negative perceptions based on misinformation, may be especially harmful or stigmatizing within the context of disclosure (i.e., telling another about one's opioid use disorder history or treatment), inhibiting important recovery outcomes and sources of social support.

METHODS

Therefore, using the Disclosure Process Model as a framework, the current study seeks to characterize and compare participants' perceptions of stigmatizing reactions to their disclosures of MOUD use that stem from misinformation about methadone or buprenorphine/naloxone. Participants included people who are actively receiving MOUD as treatment.

RESULTS

Results suggest that participants (N = 52) receiving both types of medications experienced similar stigmatizing reactions to disclosures. Participants also reported treatment consequences of misinformed reactions to their disclosure, such as dropping out of support groups (e.g., Narcotics Anonymous) or prematurely ending their medication use. Further, the paper provides participants' recommendations for avoiding or managing misinformed disclosure reactions.

CONCLUSIONS

Short-term intervention efforts may promote strategies to manage misinformation, equipping individuals to respond to misinformation surrounding their medication use. Long-term interventions may target misinformation about methadone and buprenorphine/naloxone medications to increase health literacy, reduce stigma, and combat cultural ambivalence within communities, as well as promote recovery among people receiving medications for opioid use disorder.

Для цитирования: Brousseau Natalie M, Farmer Heather, Karpyn Allison, Laurenceau Jean-Philippe, Kelly John F, Hill Elizabeth C, Earnshaw Valerie A. Qualitative characterizations of misinformed disclosure reactions to medications for opioid use disorders and their consequences.. Journal of substance abuse treatment. 2021. DOI: 10.1016/j.jsat.2021.108593.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.